Top Markets
Coin of the day
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.

China BCT Pharmacy Group, Inc.

CNBI
Rank in Stocks #42162
China BCT Pharmacy Group, Inc. functions as a comprehensive pharmaceutical... China BCT Pharmacy Group, Inc. functions as a comprehensive pharmaceutical enterprise within the People's Republic of China, conducting its operations through various subsidiary companies. Its business activities are primarily categorized into three distinct divisions: Pharmaceutical Distribution, Retail Pharmacy, and Pharmaceutical Manufacturing. The Pharmaceutical Distribution division procures a diverse array of medicinal goods from various suppliers, subsequently supplying them to a broad client base that includes hospitals, retail drug stores, other wholesale distributors, clinics, medical centers, and individual consumers. Its extensive inventory, numbering approximately 8,000 distinct items, encompasses both branded and generic prescription medications, over-the-counter remedies, traditional Western and Chinese medicines, personal care products, medical supplies, Chinese herbal remedies, and medical instruments. Through its Retail Pharmacy segment, the company manages a network of 196 directly owned pharmacies, predominantly located in Guangxi province, operating under the "Baicaotang" brand. These outlets provide expert pharmaceutical services and offer a broad assortment of health-related products. This range includes prescription and non-prescription drugs, refined and roughly processed traditional Chinese herbal medicines, family planning items, and various other pharmaceutical and healthcare products. The Pharmaceutical Manufacturing division, operating under the "Asio" brand, is responsible for producing and marketing a range of generic and clinical pharmaceuticals. This includes treatments for inflammation and bacterial infections, oncology drugs, cardiovascular medications, and hepatitis therapies. Key products manufactured by the company include Levodopa, Tabellae Sarcandrae, Rotandine Sulfate, Corydalis Saxicola Bunting, and Ethacridine Lactate injection. The company was originally known as China Baicaotang Medicine Limited before adopting its current name, China BCT Pharmacy Group, Inc., in March 2010. Its corporate headquarters are situated in Liuzhou, People's Republic of China.
Share Price
$0.0001
Last synced: 2025-06-02
Market Cap
$3.82K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
CN
Trade China BCT Pharmacy Group, Inc. (CNBI)

Category

Price of CNBI with the market cap of B
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
CNBI
$0.0001
Market Capitalization of China BCT Pharmacy Group, Inc.(CNBI)
Market Cap: $3.82K
As of August 2026 China BCT Pharmacy Group, Inc. has a market cap of $3.82K. This makes China BCT Pharmacy Group, Inc. the world's 42162nd most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of China BCT Pharmacy Group, Inc. from 2010 to 2026
CNBI compared with Top 5 Most Popular stocks
Price of CNBI Asset B Mkt. of B Results
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$141,094 $3.82K
$5.383T +141,094,292,751.11%
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$115,934 $3.82K
$4.423T +115,934,159,328.25%
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$109,041 $3.82K
$4.160T +109,040,531,695.15%
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$96,013.21 $3.82K
$3.663T +96,013,217,450.08%
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$75,777.19 $3.82K
$2.891T +75,777,195,420.53%